Yahoo Finance Ryman Healthcare Limited (NZSE:RYM) insiders placed bullish bets worth NZ$1.7m in the last 12 months
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Ryman Healthcare Limited's (NZSE:RYM) case, it's fantastic news for shareholders.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
Check out our latest analysis for Ryman Healthcare
The Last 12 Months Of Insider Transactions At Ryman Healthcare
The insider, Gordon MacLeod, made the biggest insider sale in the last 12 months. That single transaction was for NZ$967k worth of shares at a price of NZ$14.63 each. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The silver lining is that this sell-down took place above the latest price (NZ$9.57). So it is hard to draw any strong conclusion from it.
In the last twelve months insiders purchased 130.77k shares for NZ$1.7m. But insiders sold 96.85k shares worth NZ$1.4m. In total, Ryman Healthcare insiders bought more than they sold over the last year. The average buy price was around NZ$12.97. This is nice to see since it implies that insiders might see value around current prices. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
Ryman Healthcare is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Does Ryman Healthcare Boast High Insider Ownership?
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Ryman Healthcare insiders own 14% of the company, currently worth about NZ$649m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
What Might The Insider Transactions At Ryman Healthcare Tell Us?
The fact that there have been no Ryman Healthcare insider transactions recently certainly doesn't bother us. On a brighter note, the transactions over the last year are encouraging. With high insider ownership and encouraging transactions, it seems like Ryman Healthcare insiders think the business has merit. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To that end, you should learn about the 3 warning signs we've spotted with Ryman Healthcare (including 1 which is significant).
Of course Ryman Healthcare may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
